2024 Canadian Urological Association guideline: Female stress urinary incontinence

Affiliations

¹ Southern Alberta Institute of Urology & Section of Urology, Department of Surgery, University of Calgary, Calgary, AB, Canada.
² Division of Urology, Department of Surgery, Memorial University, St. John's, NL, Canada.
³ North Island Hospital Comox Valley, Courtenay, BC, Canada.
⁴ Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada.
⁵ École de réadaptation, Université de Montréal, Montreal, QC, Canada.
⁶ Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada.
⁷ Kelowna General Hospital, Kelowna, BC, Canada.
⁸ Division of Urology, Department of Surgery, Université Laval, Quebec, QC, Canada.
⁹ Division of Urology, Department of Surgery, Western University, London, ON, Canada.

PMID: 38648655
PMCID: PMC11034962
DOI: 10.5489/cuaj.8751

2024 Canadian Urological Association guideline: Female stress urinary incontinence

Kevin Carlson et al. Can Urol Assoc J. 2024 Apr.

. 2024 Apr;18(4):83-102.

doi: 10.5489/cuaj.8751.

Authors

Affiliations

¹ Southern Alberta Institute of Urology & Section of Urology, Department of Surgery, University of Calgary, Calgary, AB, Canada.
² Division of Urology, Department of Surgery, Memorial University, St. John's, NL, Canada.
³ North Island Hospital Comox Valley, Courtenay, BC, Canada.
⁴ Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada.
⁵ École de réadaptation, Université de Montréal, Montreal, QC, Canada.
⁶ Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada.
⁷ Kelowna General Hospital, Kelowna, BC, Canada.
⁸ Division of Urology, Department of Surgery, Université Laval, Quebec, QC, Canada.
⁹ Division of Urology, Department of Surgery, Western University, London, ON, Canada.

PMID: 38648655
PMCID: PMC11034962
DOI: 10.5489/cuaj.8751

No abstract available

PubMed Disclaimer

Conflict of interest statement

COMPETING INTERESTS: Dr. Carlson has been an advisory board member for AbbVie and received honoraria for CME development. Dr. Andrews has been an advisory board member for AbbVie. Dr. Baverstock has been a speaker for Astellas and Boston Scientific; and an advisory board member/speaker for AbbVie. Dr. Nadeau has been an advisory board member for AbbVie and Astellas; a consultant for AbbVie, Boston Scientific, and Searchlight Pharma; and a speaker for AbbVie and Laborie. Dr. Welk has been a consultant for BD Company. The remaining authors do not report any competing personal or financial interests related to this work.

Figures

**Figure 1**
Suggested management approach for isolated residual or recurrent female stress urinary incontinence (FSUI) following a single prior midurethral sling (MUS). AUS: artificial urinary sphincter; OAB: overactive bladder.

See this image and copyright information in PMC

Cited by

Efficacy and Tolerance of the Tampsec Vaginal Tampon for Treating Stress Urinary Incontinence. A Randomized Controlled Trial.
Diez-Itza I, Cassadó J, Martin A, Muñoz E, López-Herrero E, Bauset C, Mancisidor M, Sarasqueta C. Diez-Itza I, et al. Int Urogynecol J. 2025 May;36(5):1011-1018. doi: 10.1007/s00192-025-06060-x. Epub 2025 Jan 30. Int Urogynecol J. 2025. PMID: 39883126 Clinical Trial.
Efficacy of Two Modes of Transvaginal Temperature-Controlled Radiofrequency for Female Stress Urinary Incontinence.
Wang XX, Xu Y, Song YF, Zheng XH, Jiang XX, Lin CQ. Wang XX, et al. Int Urogynecol J. 2025 Feb 13. doi: 10.1007/s00192-025-06065-6. Online ahead of print. Int Urogynecol J. 2025. PMID: 39945801
The Treatment Selection for a 36-Year-Old Woman With Stress Urinary Incontinence Using a Discrete Mathematical Approach: A Case Report.
Okui N. Okui N. Cureus. 2024 May 29;16(5):e61314. doi: 10.7759/cureus.61314. eCollection 2024 May. Cureus. 2024. PMID: 38947714 Free PMC article.

References

1. Aoki Y, Brown HW, Brubaker L, et al. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3:17042. doi: 10.1038/nrdp.2017.42. - DOI - PMC - PubMed
1. Milsom I, Altman D, Cartwright R, et al. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. In: Abrams P, Wagg A, Wein A, editors. International Consultation on Incontinence, C.L. International Continence Society; Bristol: 2017. pp. 1–142.
1. Bettez M, Tu le M, Carlson K, et al. 2012 update: Guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can Urol Assoc J. 2012;6:354–63. doi: 10.5489/cuaj.12248. - DOI - PMC - PubMed
1. Nambiar AK, Arlandis S, Bo K, et al. European Association of Urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82:49–59. doi: 10.1016/j.eururo.2022.01.045. - DOI - PubMed
1. Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol. 2017;198:875–83. doi: 10.1016/j.juro.2017.06.061. - DOI - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

2024 Canadian Urological Association guideline: Female stress urinary incontinence

Affiliations

2024 Canadian Urological Association guideline: Female stress urinary incontinence

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources